FSD Pharma Inc. | Finanzwire

Basculer en Français

8302	Companies
115146	Keywords
55466	Articles
62541	Press releases

Home
Companies
FSD Pharma Inc.

PRESS RELEASE

published on 02/26/2024 at 14:00, 8 months 24 days ago

FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM)
FSD Pharma Inc. announced an agreement for a clinical trial to test unbuzzd™ effects on faster alcohol metabolism. The trial aims to confirm the supplement's potential benefits in sobering up from alcohol intoxication

FSD Pharma Inc. Biopharmaceutical Clinical Trial Unbuzzd™ Alcohol Metabolism
BRIEF

published on 02/26/2024 at 14:00, 8 months 24 days ago

FSD Pharma launches a clinical trial to test the effectiveness of unbuzzd™

FSD Pharma Clinical Test Unbuzzd™ Alcohol Metabolism Accelerated Sobriety
PRESS RELEASE

published on 02/17/2024 at 01:10, 9 months 5 days ago

FSD Pharma Announces US ATM Offering
FSD Pharma announces an at-the-market offering agreement with H.C. Wainwright & Co., LLC to sell Class B Shares for up to US$11,154,232. The Company may use proceeds for clinical trials & general corporate purposes

FSD Pharma Biopharmaceutical At-the-market Offering H.C. Wainwright & Co. Class B Shares
PRESS RELEASE

published on 02/06/2024 at 13:00, 9 months 15 days ago

Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million
FSD Pharma Inc. announced that the Court of Appeal for Ontario affirmed the Judgment entered by the Superior Court of Justice. The company also filed a Petition to Confirm Arbitration Awards in the United States District Court for the Eastern District of Pennsylvania

FSD Pharma Inc. Court Of Appeal Biopharmaceutical Arbitration Awards Neurodegenerative Disorders
PRESS RELEASE

published on 01/29/2024 at 22:30, 9 months 23 days ago

FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates
FSD Pharma appoints Dr. Sanjiv Chopra to its board of directors, replaces Nitin Kaushal. Also, the company retains SBS Intl Group LLC, Draper Inc., Carriage House Capital, Corp., IR Agency, Beyond Media, Issuer Direct for various services. FSD focuses on biopharmaceutical assets

FSD Pharma Dr. Sanjiv Chopra Biopharmaceutical SBS Intl Group LLC IR Agency
PRESS RELEASE

published on 01/16/2024 at 13:30, 10 months 5 days ago

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot
FSD Pharma Inc., a biopharmaceutical company, provides an update on its litigation with GBB Drink Lab, Inc., denying allegations and moving for discovery. The company remains confident in its legal position and looks forward to vindicating its rights and exposing GBB and its bully tactics.

Biopharmaceutical Company FSD Pharma Inc. Litigation Update GBB Drink Lab Inc. Alcohol Detoxification
PRESS RELEASE

published on 12/23/2023 at 01:45, 10 months 30 days ago

FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC
PRESS RELEASE

published on 12/05/2023 at 15:00, 11 months 16 days ago

FSD Pharma Inc. Announces Closing of Private Placement
FSD Pharma Inc. announces the closing of private placement and issuance of class A multiple voting shares at $1.90 per share for gross proceeds of $45.60. The proceeds will be used for general working capital purposes

Private Placement FSD Pharma Inc. Financial News Investment Class A Multiple Voting Shares
PRESS RELEASE

published on 11/30/2023 at 14:30, 11 months 21 days ago

FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement
FSD Pharma Inc. and Celly Nutrition Corp. announce completion of Plan of Arrangement including distribution of Celly Nu Shares and New FSD Pharma Securities to FSD Pharma securityholders

FSD Pharma Inc. Plan Of Arrangement Celly Nutrition Corp. Celly Nu Shares New FSD Pharma Securities
PRESS RELEASE

published on 11/28/2023 at 15:00, 11 months 23 days ago

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot Previously known as Jupiter Wellness

Accesswire

Published on 11/22/2024 at 00:00, 7 hours 49 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 9 hours 44 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 9 hours 59 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 11 hours 34 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 11 hours 39 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 07:30, 19 minutes ago

Pyrum Innovations AG publishes figures for the first nine months of 2024
Published on 11/22/2024 at 07:30, 19 minutes ago

Market entry in Belgium: cyan AG is launching a cooperation with Orange Belgium and realizing new growth opportunities
Published on 11/22/2024 at 07:30, 19 minutes ago

EQS-Adhoc: All for One Group SE resolves on Share Buyback Programme with a volume of up to EUR 7 million
Published on 11/22/2024 at 07:23, 25 minutes ago

EQS-Adhoc: Entering into agreements for the acquisition of a majority stake in OTRS AG by Optimus BidCo AG, an acquisition company of Easyvista SAS, for a purchase price of EUR 17 per share
Published on 11/22/2024 at 07:00, 49 minutes ago

Vita 34 continues to show increasing revenue, improved profitability and stronger cash generation in the third quarter of 2024

Les Echos

Published on 11/21/2024 at 06:58, 1 day ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 12 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 14 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 14 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 2 days ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE